421 related articles for article (PubMed ID: 33876268)
1. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis.
Chaudhuri D; Sasaki K; Karkar A; Sharif S; Lewis K; Mammen MJ; Alexander P; Ye Z; Lozano LEC; Munch MW; Perner A; Du B; Mbuagbaw L; Alhazzani W; Pastores SM; Marshall J; Lamontagne F; Annane D; Meduri GU; Rochwerg B
Intensive Care Med; 2021 May; 47(5):521-537. PubMed ID: 33876268
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological agents for adults with acute respiratory distress syndrome.
Lewis SR; Pritchard MW; Thomas CM; Smith AF
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis.
Adhikari N; Burns KE; Meade MO
Treat Respir Med; 2004; 3(5):307-28. PubMed ID: 15606221
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials.
Mammen MJ; Aryal K; Alhazzani W; Alexander PE
Pol Arch Intern Med; 2020 Apr; 130(4):276-286. PubMed ID: 32186831
[TBL] [Abstract][Full Text] [Related]
6. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis.
Ruan SY; Lin HH; Huang CT; Kuo PH; Wu HD; Yu CJ
Crit Care; 2014 Apr; 18(2):R63. PubMed ID: 24708846
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data.
Chang X; Li S; Fu Y; Dang H; Liu C
Respir Res; 2022 Nov; 23(1):301. PubMed ID: 36333729
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of corticosteroids in acute respiratory distress syndrome: An overview of meta-analyses.
Rashid M; Khan S; Datta D; Thunga G; Chandran VP; Balakrishnan A; Shanbhag V; Acharya RV; Nair S
Int J Clin Pract; 2021 Nov; 75(11):e14645. PubMed ID: 34310805
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review.
Landolf KM; Lemieux SM; Rose C; Johnston JP; Adams CD; Altshuler J; Berger K; Dixit D; Effendi MK; Heavner MS; Lemieux D; Littlefield AJ; Nei AM; Owusu KA; Rinehart M; Robbins B; Rouse GE; Thompson Bastin ML
Pharmacotherapy; 2022 Jan; 42(1):71-90. PubMed ID: 34662448
[TBL] [Abstract][Full Text] [Related]
10. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
Hasan SS; Capstick T; Ahmed R; Kow CS; Mazhar F; Merchant HA; Zaidi STR
Expert Rev Respir Med; 2020 Nov; 14(11):1149-1163. PubMed ID: 32734777
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids in adult respiratory distress syndrome - an inconvenient truth?
Shulman R; Montanari C; Pinheiro I; Longobardo A; Benhalm S; Polhill S; Singer M; Bellingan G; Arulkumaran N
Int J Pharm Pract; 2021 Dec; 29(6):642-644. PubMed ID: 34469546
[TBL] [Abstract][Full Text] [Related]
12. Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS.
Lamouche-Wilquin P; Souchard J; Pere M; Raymond M; Asfar P; Darreau C; Reizine F; Hourmant B; Colin G; Rieul G; Kergoat P; Frérou A; Lorber J; Auchabie J; La Combe B; Seguin P; Egreteau PY; Morin J; Fedun Y; Canet E; Lascarrou JB; Delbove A
Crit Care; 2022 Aug; 26(1):233. PubMed ID: 35918776
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis.
Wu D; Li Y; Dong SH; Gao Y
Ann Saudi Med; 2024; 44(3):167-182. PubMed ID: 38853475
[TBL] [Abstract][Full Text] [Related]
14. The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
Katz A; Altshuler D; Papadopoulos J; Amoroso N; Goldenberg R; Tarras E; Krolikowski K; Hagedorn J; Fridman D; Chen XJC; Iturrate E; Brosnahan SB
Ann Pharmacother; 2023 Jan; 57(1):5-15. PubMed ID: 35590468
[TBL] [Abstract][Full Text] [Related]
15. Effects of different corticosteroid therapy on severe COVID-19 patients: a meta-analysis of randomized controlled trials.
Tu J; Mo X; Zhang X; Xun J; Chen X; Liu Y; Jing W; Xie T
Expert Rev Respir Med; 2022 Jan; 16(1):79-89. PubMed ID: 34541972
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.
Adhikari N; Burns KE; Meade MO
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004477. PubMed ID: 15495113
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal membrane oxygenation versus mechanical ventilation alone in adults with severe acute respiratory distress syndrome: A systematic review and meta-analysis.
Zhu Y; Zhang M; Zhang R; Ye X; Wei J
Int J Clin Pract; 2021 Sep; 75(9):e14046. PubMed ID: 33486824
[TBL] [Abstract][Full Text] [Related]
18. A Review of the Evidence for Corticosteroids in COVID-19.
Johns M; George S; Taburyanskaya M; Poon YK
J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome.
Vidal-Cortés P; Del Río-Carbajo L; Nieto-Del Olmo J; Prol-Silva E; Tizón-Varela AI; Rodríguez-Vázquez A; Rodríguez-Rodríguez P; Díaz-López MD; Fernández-Ugidos P; Pérez-Veloso MA
Rev Esp Quimioter; 2021 Feb; 34(1):33-43. PubMed ID: 33317261
[TBL] [Abstract][Full Text] [Related]
20. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
